Global Biologics Contract Manufacturing Market Size & Outlook
Global biologics contract manufacturing market, 2018-2030 (US$M)
Related Markets
Global biologics contract manufacturing market highlights
- The global biologics contract manufacturing market generated a revenue of USD 12,748.1 million in 2020 and is expected to reach USD 34,692.5 million by 2030.
- The market is expected to grow at a CAGR (2021 - 2030) of 10.5% by 2030.
- In terms of segment, mabs accounted for a revenue of USD 7,381.2 million in 2020.
- MABs is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, South Africa is expected to register the highest CAGR from 2021 to 2030.
Global data book summary
| Market revenue in 2020 | USD 12,748.1 million |
| Market revenue in 2030 | USD 34,692.5 million |
| Growth rate | 10.5% (CAGR from 2020 to 2030) |
| Largest segment | Mabs |
| Fastest growing segment | MABs |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | MABs, Recombinant Protein |
Other key industry trends
- In terms of revenue, the North America accounted for 41.1% of the global biologics contract manufacturing market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, South Africa is the fastest growing regional market and is projected to reach USD 75.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Contract Manufacturing Market Scope
Biologics Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biologics contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract manufacturing market will help companies and investors design strategic landscapes.
Mabs was the largest segment with a revenue share of 57.9% in 2020. Horizon Databook has segmented the Global biologics contract manufacturing market based on mabs, recombinant protein covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Biologics Contract Manufacturing Product Outlook (Revenue, USD Million, 2018-2030)
- MABs
- Recombinant Protein
- Others
- Global Biologics Contract Manufacturing Indication Outlook (Revenue, USD Million, 2018-2030)
- Oncology
- Immunological Disorders
- Cardiovascular Disorders (CVDs)
- Hematological Disorders
- Others
Reasons to subscribe to Global biologics contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biologics contract manufacturing market databook
-
Our clientele includes a mix of biologics contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biologics contract manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global biologics contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biologics contract manufacturing market size, by regions, 2018-2030 (US$M)
Top 10 countries: Biologics contract manufacturing market size, 2020 (US$M)
Global biologics contract manufacturing market share, by product, 2020 & 2030 (%, US$M)
Biologics contract manufacturing market: Opportunity assessment by country
Global biologics contract manufacturing market, by region, 2020 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
